Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses
Authors:
Top Cited Papers
Open Access
Abstract
No abstract availableKeywords
Funding Information
- American Association of Immunologists (R01AI155727)
- American Association of Immunologists (5R01AI158832)
- American Association of Immunologists (T32AI055428)
- American Association of Immunologists (75N93021C00015)
- Magyar Tudományos Akadémia (LP2017-7/2017)
- Charles A King Trust
- Damon Runyon Cancer Research Foundation
- National Institutes of Health (P01AI158571)
- National Institutes of Health (R01AI153064)
- National Institutes of Health (U19AI181968)
- National Institutes of Health (R01AI146101)
- National Institutes of Health (T32AI055400)
- National Institutes of Health (R01AI168312)
This publication has 86 references indexed in Scilit:
- Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases2024
- Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsCell, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- UCell: Robust and scalable single-cell gene signature scoringComputational and Structural Biotechnology Journal, 2021
- PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin ImmunityCell Reports, 2020
- Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive ImmunityCell Reports, 2020
- The role of type I interferons in CD4+ T cell differentiationImmunology Letters, 2019
- Parsing the Interferon Transcriptional Network and Its Disease AssociationsCell, 2016
- Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper CellsImmunity, 2009
- Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNAImmunity, 2005